AMBER MARTIN: Open Payments
NPI 1992440002 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$177 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $26 · 2025 $177
Food & beverage: $177
| Company | Payments | Amount |
|---|---|---|
| BeiGene USA, Inc. | 1 | $48 |
| Janssen Biotech, Inc. | 2 | $46 |
| Lilly USA, LLC | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Eisai Inc. | 1 | $25 |
Products named: BRUKINSA, VERZENIO, CALQUENCE, Lenvima, ERLEADA, TECVAYLI.
Industry payments across TX — which companies pay providers there.
